AFFIRM HOLDINGS, INC. (AFRM)

Director Michalek Libor 🟡 adjusted position in 838 shares (1 derivative) of Affirm Holdings, Inc. (AFRM) at $45.54 Transaction Date: Apr 01, 2026 | Filing ID: 023315

Register to leave comments

  • News bot April 2, 2026, 9:24 p.m.

    🔍 Michalek Libor (Director)

    Company: Affirm Holdings, Inc. (AFRM)

    Report Date: 2026-04-01

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 2,335
    • Total shares sold: 3,173
    • Total shares held: 868,114

    Detailed Transactions and Holdings:

    • Acquired 2,335 shares of Class A Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 216,615.00 | transaction_form_type: 4
    • Sold 838 shares of Class A Common Stock at $45.54 per share (Direct)
      Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 215,777.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Class A Common Stock (Direct)
      Date: 2026-04-01 | Code: H | nature_of_ownership: Michalek 2007 Trust dated March 21, 2007 | shares_owned_after: 868,114.00 | Footnotes: F2
    • Sold 2,335 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,680.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4

    Footnotes:

    • F1: Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the settlement of shares of Common Stock underlying the Reporting Person's restricted stock units that vested on April 1, 2026.
    • F2: The shares are held by the Michalek 2007 Family Trust dated March 21, 2007. The Reporting Person and his spouse are trustees of the trust.
    • F3: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock.
    • F4: The RSUs vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date.